Can a brain pacemaker tame Treatment-Resistant depression?

NCT ID NCT03437928

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial investigates whether a next-generation deep brain stimulation (DBS) system can reduce symptoms in people with major depression that hasn't improved with standard treatments. The device uses directional current steering to precisely target brain networks thought to be involved in depression. Researchers aim to see if this individualized approach is safe and can lead to meaningful improvements in mood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
directional deep brain stimulation using Boston Scientific Vercise leads and implanted pulse generators
What this could lead to
If successful, this could offer a new treatment option for people with severe depression that hasn't responded to other therapies.
What could go wrong
This is a small, early-stage trial with only 12 participants, so results may not apply broadly. Deep brain stimulation is an invasive brain surgery with risks such as infection, bleeding, or mood changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine

    ACTIVE_NOT_RECRUITING

    Houston, Texas, 77030, United States

  • University of Texas Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.